KZA 0.00% 8.0¢ kazia therapeutics limited

Ann Coming, page-10

  1. 442 Posts.
    lightbulb Created with Sketch. 45
    The consolidated entity anticipates completing the Cantrixil toxicology evaluation by the end of 2015.This information will enable regulators, such as the FDA and clinical investigators to assess the drug’s safety, ascribe a starting dose in humans, and establish AE/SAE monitoring criteria in humans.

    Ninja -C what you read at the top of page 6 is the wish list for the coming year. The above line is how it stands at present.

    Cheers
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.